Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01662284 · ClinicalTrials.gov registry record
Study of 124I-NM404 in Advanced Solid Malignancies
A clinical trial, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- 12
- Enrollment target
NCT01662284: Clinical Trial study, sponsored by University of Wisconsin, Madison.
NCT01662284 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01662284 was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the use of investigational compound 124I-NM404 for accurate detection and characterization of a wide variety of solid primary and metastatic malignancies anywhere in the body.
Primary Outcome
To determine the optimal imaging parameters (dose, acquisition time, imaging time post injection, normal organ and tumor dosimetry) of 124I-NM404 in subjects with advanced solid malignancies with one of the following tumor types: triple negative breast, prostate, colorectal, gastric, ovarian, pancreatic, esophageal, soft tissue sarcoma, and head \& neck cancer
Interventions
- DRUG 124I-NM404
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-07 |
| Est. Completion | 2016-05 |
Why NCT01662284 stopped before completion
NCT01662284 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 124I-NM404 is the first listed.
NCT01662284 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01662284 about?
NCT01662284 is a clinical study titled "Study of 124I-NM404 in Advanced Solid Malignancies". The purpose of this study is to assess the use of investigational compound 124I-NM404 for accurate detection and characterization of a wide variety of solid primary and metastatic malignancies anywhere in the body.
What is the current status of trial NCT01662284?
This trial is currently terminated. The enrollment target is 12 participants. The study started on 2012-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01662284?
The interventions under investigation include: 124I-NM404 (DRUG).
Who is sponsoring clinical trial NCT01662284?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia